comparemela.com

Latest Breaking News On - David szekeres - Page 7 : comparemela.com

Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference

/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and.

New yorkUnited statesDavid szekeresExchange commissionPrnewswire heron therapeutics incHeron therapeutics incGlobal healthcare conferenceInvestor resourcesHeron therapeuticsPrivate securities litigation reform actMedia contactVice presidentChief operating

Heron Therapeutics Presents ZYNRELEF® Data at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting

/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and.

United kingdomDavid szekeresCraig safferPrnewswire heron therapeutics incEuropean commissionSociety for obstetric anesthesiaDrug administrationExchange commissionEuropean unionHealth canadaCoast ob gyn incHeron therapeutics incObstetric anesthesiaAnnual meetingWest coastSafety information

Heron Therapeutics, Inc (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript

Heron Therapeutics, Inc. (NASDAQ:NASDAQ:HRTX) Q1 2022 Results Conference Call May 09, 2022 04:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John.

Josh schimmerSerge belangerJohn poyhonenDavid szekeresKimberly manhardKelly shiBrandon folkesCompany participantsCantor fitzgeraldHeron therapeutics incSymphony healthDrug developmentHeron therapeuticsConference call mayChief commercialHeron therapeutics first quarter

Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022

/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing.

David szekeresExchange commissionPrnewswire heron therapeutics incHeron therapeutics incInvestor relationsHeron therapeuticsPrivate securities litigation reform actMedia contactVice presidentChief operating

Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference

/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing.

David szekeresExchange commissionPrnewswire heron therapeutics incHeron therapeutics incAnnual virtual needham healthcare conferenceInvestor resourcesHeron therapeuticsPrivate securities litigation reform actMedia contactVice presidentChief operating

vimarsana © 2020. All Rights Reserved.